Literature DB >> 27291509

Atrial fibrillation in inherited cardiac channelopathies: From mechanisms to management.

Andres Enriquez1, Charles Antzelevitch2, Verdah Bismah3, Adrian Baranchuk3.   

Abstract

Atrial fibrillation (AF) is prevalent in cardiac channelopathies and may be the presenting feature in some patients. The pathogenesis is related to the primary ion channel dysfunction in atrial myocytes that affects atrial conduction or repolarization. The development of AF is associated with adverse outcomes, and its management is challenging in these patients. In this article we review the current information on the prevalence, risk factors, pathophysiology, and treatment of AF in specific cardiac channelopathies.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Brugada syndrome; Catecholaminergic polymorphic ventricular tachycardia; Channelopathy; Long QT syndrome; Short QT syndrome

Mesh:

Substances:

Year:  2016        PMID: 27291509     DOI: 10.1016/j.hrthm.2016.06.008

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

1.  Radiofrequency catheter ablation for drug-refractory atrial tachyarrhythmias in a patient with catecholaminergic polymorphic ventricular tachycardia: A case report.

Authors:  Satoshi Kawada; Hiroshi Morita; Atsuyuki Watanabe; Hiroshi Ito
Journal:  J Cardiol Cases       Date:  2018-12-06

Review 2.  Electrocardiogram (ECG) for the Prediction of Incident Atrial Fibrillation: An Overview.

Authors:  Yoshifusa Aizawa; Hiroshi Watanabe; Ken Okumura
Journal:  J Atr Fibrillation       Date:  2017-12-31

3.  Genomic contributors to atrial electroanatomical remodeling and atrial fibrillation progression: Pathway enrichment analysis of GWAS data.

Authors:  Daniela Husser; Laura Ueberham; Borislav Dinov; Jedrzej Kosiuk; Jelena Kornej; Gerhard Hindricks; M Benjamin Shoemaker; Dan M Roden; Andreas Bollmann; Petra Büttner
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

4.  Atrial fibrillation associated with Wolff-Parkinson-White syndrome in a patient with concomitant Brugada syndrome.

Authors:  Shaobo Shi; Tao Liu; Hector Barajas-Martinez; Ryan Pfeiffer; Hong Jiang; Congxin Huang; Dan Hu
Journal:  HeartRhythm Case Rep       Date:  2017-01-03

5.  Cardiac Sarcoidosis: What's Bad for the Ventricle is Bad for the Atria.

Authors:  Rahul N Doshi
Journal:  J Innov Card Rhythm Manag       Date:  2018-02-15

Review 6.  Atrial fibrillation: an update on management.

Authors:  Craig J McCallum; Deep Chandh Raja; Rajeev Kumar Pathak
Journal:  Aust Prescr       Date:  2019-12-02

7.  Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation.

Authors:  Liang Hong; Meihong Zhang; Olivia Thao Ly; Hanna Chen; Arvind Sridhar; Erin Lambers; Brandon Chalazan; Seock-Won Youn; Mark Maienschein-Cline; Leonid Feferman; Sang-Ging Ong; Joseph C Wu; Jalees Rehman; Dawood Darbar
Journal:  Stem Cell Reports       Date:  2021-05-20       Impact factor: 7.765

8.  Hub Genes Identification, Small Molecule Compounds Prediction for Atrial Fibrillation and Diagnostic Model Construction Based on XGBoost Algorithm.

Authors:  Lingzhi Yang; Yunwei Chen; Wei Huang
Journal:  Front Cardiovasc Med       Date:  2022-07-14

9.  The Subcellular Distribution of Ryanodine Receptors and L-Type Ca2+ Channels Modulates Ca2+-Transient Properties and Spontaneous Ca2+-Release Events in Atrial Cardiomyocytes.

Authors:  Henry Sutanto; Bart van Sloun; Patrick Schönleitner; Marc A M J van Zandvoort; Gudrun Antoons; Jordi Heijman
Journal:  Front Physiol       Date:  2018-08-14       Impact factor: 4.566

10.  In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome.

Authors:  Dominic G Whittaker; Jules C Hancox; Henggui Zhang
Journal:  Front Physiol       Date:  2019-01-11       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.